Profil
S.
Michael Rothenberg worked as Vice President-Research & Development at Loxo Oncology, Inc. from 2015 to 2020.
He completed his undergraduate degree at Yale University and his doctorate at Stanford University School of Medicine.
Anciens postes connus de S. Michael Rothenberg
| Sociétés | Poste | Fin |
|---|---|---|
| LOXO ONCOLOGY INC | Chief Tech/Sci/R&D Officer | 01/01/2020 |
Formation de S. Michael Rothenberg
| Yale University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
